Works matching AU Dent, Rebecca

Results: 50
    1

    Molecular determinants of response to neoadjuvant pembrolizumab plus chemotherapy in patients with high-risk, early-stage, triple-negative breast cancer: exploratory analysis of the open-label, multicohort phase 1b KEYNOTE-173 study.

    Published in:
    Breast Cancer Research, 2025, v. 27, n. 1, p. 1, doi. 10.1186/s13058-024-01946-y
    By:
    • Dent, Rebecca;
    • Cortés, Javier;
    • Park, Yeon Hee;
    • Muñoz-Couselo, Eva;
    • Kim, Sung-Bae;
    • Sohn, Joohyuk;
    • Im, Seock-Ah;
    • Holgado, Esther;
    • Foukakis, Theodoros;
    • Kümmel, Sherko;
    • Yearley, Jennifer;
    • Wang, Anran;
    • Nebozhyn, Michael;
    • Huang, Lingkang;
    • Cristescu, Razvan;
    • Jelinic, Petar;
    • Karantza, Vassiliki;
    • Schmid, Peter
    Publication type:
    Article
    2
    3
    4
    5

    Neoadjuvant pembrolizumab plus chemotherapy/adjuvant pembrolizumab for early-stage triple-negative breast cancer: quality-of-life results from the randomized KEYNOTE-522 study.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 10, p. 1654, doi. 10.1093/jnci/djae129
    By:
    • Dent, Rebecca;
    • Cortés, Javier;
    • Pusztai, Lajos;
    • McArthur, Heather;
    • Kümmel, Sherko;
    • Bergh, Jonas;
    • Denkert, Carsten;
    • Park, Yeon Hee;
    • Hui, Rina;
    • Harbeck, Nadia;
    • Takahashi, Masato;
    • Untch, Michael;
    • Fasching, Peter A;
    • Cardoso, Fatima;
    • Haiderali, Amin;
    • Jia, Liyi;
    • Nguyen, Allison Martin;
    • Pan, Wilbur;
    • O'Shaughnessy, Joyce;
    • Schmid, Peter
    Publication type:
    Article
    6
    7
    8
    9
    10
    11

    Triple-negative breast cancers.

    Published in:
    Expert Review of Anticancer Therapy, 2023, v. 23, n. 10, p. 1041, doi. 10.1080/14737140.2023.2257393
    By:
    • Narod, Steven A;
    • Dent, Rebecca
    Publication type:
    Article
    12
    13
    14

    Pembrolizumab Plus Chemotherapy Followed by Pembrolizumab in Patients With Early Triple-Negative Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.

    Published in:
    JAMA Network Open, 2023, v. 6, n. 11, p. e2342107, doi. 10.1001/jamanetworkopen.2023.42107
    By:
    • Takahashi, Masato;
    • Cortés, Javier;
    • Dent, Rebecca;
    • Pusztai, Lajos;
    • McArthur, Heather;
    • Kümmel, Sherko;
    • Denkert, Carsten;
    • Park, Yeon Hee;
    • Im, Seock-Ah;
    • Ahn, Jin-Hee;
    • Mukai, Hirofumi;
    • Huang, Chiun-Sheng;
    • Chen, Shin-Cheh;
    • Kim, Min Hwan;
    • Jia, Liyi;
    • Li, Xin Tong;
    • Tryfonidis, Konstantinos;
    • Karantza, Vassiliki;
    • Iwata, Hiroji;
    • Schmid, Peter
    Publication type:
    Article
    15

    Association between Breast Cancer Polygenic Risk Score and Chemotherapy-Induced Febrile Neutropenia: Null Results.

    Published in:
    Cancers, 2022, v. 14, n. 11, p. 2714, doi. 10.3390/cancers14112714
    By:
    • Ong, Seeu Si;
    • Ho, Peh Joo;
    • Khng, Alexis Jiaying;
    • Lim, Elaine Hsuen;
    • Wong, Fuh Yong;
    • Tan, Benita Kiat-Tee;
    • Lim, Swee Ho;
    • Tan, Ern Yu;
    • Tan, Su-Ming;
    • Tan, Veronique Kiak Mien;
    • Dent, Rebecca;
    • Tan, Tira Jing Ying;
    • Ngeow, Joanne;
    • Madhukumar, Preetha;
    • Hamzah, Julie Liana Bte;
    • Sim, Yirong;
    • Lim, Geok Hoon;
    • Pang, Jinnie Siyan;
    • Alcantara, Veronica Siton;
    • Chan, Patrick Mun Yew
    Publication type:
    Article
    16

    Discordance Between Advanced Cancer Patients' Perceived and Preferred Roles in Decision Making and its Association with Psychological Distress and Perceived Quality of Care.

    Published in:
    Patient, 2021, v. 14, n. 5, p. 581, doi. 10.1007/s40271-020-00480-1
    By:
    • Ozdemir, Semra;
    • Tian, Yubing;
    • Malhotra, Chetna;
    • Harding, Richard;
    • Koh, Gerald Choon Huat;
    • Kumarakulasinghe, Nesaretnam Barr;
    • Lee, Lai Heng;
    • Mon, Ssu Wynn;
    • Finkelstein, Eric;
    • COMPASS Study Group;
    • Singh, Ratna;
    • Dent, Rebecca A.;
    • Yeo, Wee Lee;
    • Cheung, Yin Bun;
    • Malhotra, Rahul;
    • Kanesvaran, Ravindran;
    • Yee, Alethea Chung Pheng;
    • Chan, Noreen;
    • Wu, Huei Yaw;
    • Chin, Soh Mun
    Publication type:
    Article
    17
    18

    A prospective cohort study assessing aggressive interventions at the end-of-life among patients with solid metastatic cancer.

    Published in:
    BMC Palliative Care, 2022, v. 21, p. 1, doi. 10.1186/s12904-022-00970-z
    By:
    • Malhotra, Chetna;
    • Bundoc, Filipinas;
    • Chaudhry, Isha;
    • Teo, Irene;
    • Ozdemir, Semra;
    • Finkelstein, Eric;
    • on behalf of COMPASS study group;
    • Dent, Rebecca A.;
    • Kumarakulasinghe, Nesaretnam Barr;
    • Cheung, Yin Bun;
    • Malhotra, Rahul;
    • Kanesvaran, Ravindran;
    • Yee, Alethea Chung Pheng;
    • Chan, Noreen;
    • Wu, Huei Yaw;
    • Chin, Soh Mun;
    • Allyn, Hum Yin Mei;
    • Yang, Grace Meijuan;
    • Neo, Patricia Soek Hui;
    • Harding, Richard
    Publication type:
    Article
    19

    Cost of Medical Care of Patients with Advanced Serious Illness in Singapore (COMPASS): prospective cohort study protocol.

    Published in:
    2018
    By:
    • Teo, Irene;
    • Singh, Ratna;
    • Malhotra, Chetna;
    • Ozdemir, Semra;
    • Dent, Rebecca A;
    • Kumarakulasinghe, Nesaretnam Barr;
    • Yeo, Wee Lee;
    • Cheung, Yin Bun;
    • Malhotra, Rahul;
    • Kanesvaran, Ravindran;
    • Yee, Alethea Chung Pheng;
    • Chan, Noreen;
    • Wu, Huei Yaw;
    • Chin, Soh Mun;
    • Allyn, Hum Yin Mei;
    • Yang, Grace Meijuan;
    • Neo, Patricia Soek Hui;
    • Nadkarni, Nivedita V;
    • Harding, Richard;
    • Finkelstein, Eric A
    Publication type:
    journal article
    20

    Replication and Meta-analysis of the Association between BDNF Val66Met Polymorphism and Cognitive Impairment in Patients Receiving Chemotherapy.

    Published in:
    Molecular Neurobiology, 2019, v. 56, n. 7, p. 4741, doi. 10.1007/s12035-018-1410-4
    By:
    • Tan, Chia Jie;
    • Lim, Sheree Wan Ting;
    • Toh, Yi Long;
    • Ng, Terence;
    • Yeo, Angie;
    • Shwe, Maung;
    • Foo, Koon Mian;
    • Chu, Pat;
    • Jain, Amit;
    • Koo, Si-Lin;
    • Dent, Rebecca A.;
    • Ng, Raymond Chee Hui;
    • Yap, Yoon Sim;
    • Lim, Elaine H.;
    • Loh, Kiley Wei-Jen;
    • Chay, Wen Yee;
    • Lee, Guek Eng;
    • Tan, Tira Jing Ying;
    • Beh, Sok Yuen;
    • Wong, Mabel
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27

    Association of mitochondrial DNA content in peripheral blood with cancer-related fatigue and chemotherapy-related cognitive impairment in early-stage breast cancer patients: a prospective cohort study.

    Published in:
    Breast Cancer Research & Treatment, 2018, v. 168, n. 3, p. 713, doi. 10.1007/s10549-017-4640-7
    By:
    • Chae, Jung-Woo;
    • Chua, Peh Siang;
    • Ng, Terence;
    • Yeo, Angie Hui Ling;
    • Shwe, Maung;
    • Gan, Yan Xiang;
    • Dorajoo, Sreemanee;
    • Foo, Koon Mian;
    • Loh, Kiley Wei-Jen;
    • Koo, Si-Lin;
    • Chay, Wen Yee;
    • Tan, Tira Jing Ying;
    • Beh, Sok Yuen;
    • Lim, Elaine Hsuen;
    • Lee, Guek Eng;
    • Dent, Rebecca;
    • Yap, Yoon Sim;
    • Ng, Raymond;
    • Ho, Han Kiat;
    • Chan, Alexandre
    Publication type:
    Article
    28

    Ten-year survival in women with primary stage IV breast cancer.

    Published in:
    Breast Cancer Research & Treatment, 2016, v. 160, n. 1, p. 145, doi. 10.1007/s10549-016-3974-x
    By:
    • Eng, Lee;
    • Dawood, Shaheenah;
    • Sopik, Victoria;
    • Haaland, Benjamin;
    • Tan, Pui;
    • Bhoo-Pathy, Nirmala;
    • Warner, Ellen;
    • Iqbal, Javaid;
    • Narod, Steven;
    • Dent, Rebecca
    Publication type:
    Article
    29
    30
    31

    Platinum-based chemotherapy in triple-negative advanced breast cancer.

    Published in:
    Breast Cancer Research & Treatment, 2014, v. 146, n. 3, p. 567, doi. 10.1007/s10549-014-3033-4
    By:
    • Villarreal-Garza, Cynthia;
    • Khalaf, Daniel;
    • Bouganim, Nathaniel;
    • Clemons, Mark;
    • Peña-Curiel, Omar;
    • Baez-Revueltas, Berenice;
    • Kiss, Alexander;
    • Kassam, Farah;
    • Enright, Katherine;
    • Verma, Sunil;
    • Pritchard, Kathleen;
    • Myers, Jeff;
    • Dent, Rebecca
    Publication type:
    Article
    32

    Randomised, phase II, placebo-controlled, trial of fulvestrant plus vandetanib in postmenopausal women with bone only or bone predominant, hormone-receptor-positive metastatic breast cancer (MBC): the OCOG ZAMBONEY study.

    Published in:
    Breast Cancer Research & Treatment, 2014, v. 146, n. 1, p. 153, doi. 10.1007/s10549-014-3015-6
    By:
    • Clemons, Mark;
    • Cochrane, Brandy;
    • Pond, Gregory;
    • Califaretti, Nadia;
    • Chia, Stephen;
    • Dent, Rebecca;
    • Song, Xinni;
    • Robidoux, Andre;
    • Parpia, Sameer;
    • Warr, David;
    • Rayson, Daniel;
    • Pritchard, Kathleen;
    • Levine, Mark
    Publication type:
    Article
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42

    TROPION-Breast04: a randomized phase III study of neoadjuvant datopotamab deruxtecan (Dato-DXd) plus durvalumab followed by adjuvant durvalumab versus standard of care in patients with treatment-naïve early-stage triple negative or HR-low/HER2− breast cancer

    Published in:
    Therapeutic Advances in Medical Oncology, 2025, p. 1, doi. 10.1177/17588359251316176
    By:
    • McArthur, Heather L.;
    • Tolaney, Sara M.;
    • Dent, Rebecca;
    • Schmid, Peter;
    • Asselah, Jamil;
    • Liu, Qiang;
    • Meisel, Jane Lowe;
    • Niikura, Naoki;
    • Park, Yeon Hee;
    • Werutsky, Gustavo;
    • Bianchini, Giampaolo;
    • Andersen, Jay C.;
    • Kozarski, Robert;
    • Rokutanda, Nana;
    • Pistilli, Barbara;
    • Loibl, Sibylle
    Publication type:
    Article
    43
    44

    A prospective study of docetaxel-associated pain syndrome.

    Published in:
    2018
    By:
    • Chiu, Nicholas;
    • Liying Zhang;
    • Dent, Rebecca;
    • Giotis, Angie;
    • van Draanen, Jenna;
    • Gallo-Hershberg, Daniela;
    • Chiu, Leonard;
    • Chow, Ronald;
    • Bo Angela Wan;
    • Pasetka, Mark;
    • Stinson, Jordan;
    • Stacey, Erica;
    • Verma, Sunil;
    • Lam, Henry;
    • Chow, Edward;
    • DeAngelis, Carlo;
    • Zhang, Liying;
    • Wan, Bo Angela
    Publication type:
    journal article
    45
    46

    Impact of Cryotherapy on Sensory, Motor, and Autonomic Neuropathy in Breast Cancer Patients Receiving Paclitaxel: A Randomized, Controlled Trial.

    Published in:
    Frontiers in Neurology, 2020, v. 11, p. N.PAG, doi. 10.3389/fneur.2020.604688
    By:
    • Ng, Ding Quan;
    • Tan, Chia Jie;
    • Soh, Boon Chua;
    • Tan, Mabel May Leng;
    • Loh, Soon Yue;
    • Tan, Yam Eng;
    • Ong, Hui Hui;
    • Teng, Peggy Pei Chee;
    • Chan, Jack Junjie;
    • Chay, Wen Yee;
    • Lee, Joycelyn;
    • Lai, Gillianne;
    • Beh, Sok Yuen;
    • Tan, Tira Jing Ying;
    • Yap, Yoon Sim;
    • Lee, Guek Eng;
    • Wong, Mabel;
    • Dent, Rebecca;
    • Lo, Yew Long;
    • Chan, Alexandre
    Publication type:
    Article
    47

    Ipatasertib plus paclitaxel for PIK3CA/AKT1/PTEN-altered hormone receptor-positive HER2-negative advanced breast cancer: primary results from cohort B of the IPATunity130 randomized phase 3 trial.

    Published in:
    Breast Cancer Research & Treatment, 2022, v. 191, n. 3, p. 565, doi. 10.1007/s10549-021-06450-x
    By:
    • Turner, Nicholas;
    • Dent, Rebecca A.;
    • O'Shaughnessy, Joyce;
    • Kim, Sung-Bae;
    • Isakoff, Steven J.;
    • Barrios, Carlos;
    • Saji, Shigehira;
    • Bondarenko, Igor;
    • Nowecki, Zbigniew;
    • Lian, Qinshu;
    • Reilly, Sarah-Jayne;
    • Hinton, Heather;
    • Wongchenko, Matthew J.;
    • Kovic, Bruno;
    • Mani, Aruna;
    • Oliveira, Mafalda
    Publication type:
    Article
    48

    Final results of the double-blind placebo-controlled randomized phase 2 LOTUS trial of first-line ipatasertib plus paclitaxel for inoperable locally advanced/metastatic triple-negative breast cancer.

    Published in:
    Breast Cancer Research & Treatment, 2021, v. 189, n. 2, p. 377, doi. 10.1007/s10549-021-06143-5
    By:
    • Dent, Rebecca;
    • Oliveira, Mafalda;
    • Isakoff, Steven J.;
    • Im, Seock-Ah;
    • Espié, Marc;
    • Blau, Sibel;
    • Tan, Antoinette R.;
    • Saura, Cristina;
    • Wongchenko, Matthew J.;
    • Xu, Na;
    • Bradley, Denise;
    • Reilly, Sarah-Jayne;
    • Mani, Aruna;
    • Kim, Sung-Bae;
    • on behalf of the LOTUS investigators;
    • Lee, K. S.;
    • Sohn, J. H.;
    • Kim, J. H.;
    • Seo, J. H.;
    • Kim, J. S.
    Publication type:
    Article
    49

    Brain-derived neurotrophic factor genetic polymorphism (rs6265) is protective against chemotherapy-associated cognitive impairment in patients with early-stage breast cancer.

    Published in:
    Neuro-Oncology, 2016, v. 18, n. 2, p. 244, doi. 10.1093/neuonc/nov162
    By:
    • Ng, Terence;
    • Shu Mei Teo;
    • Hui Ling Yeo;
    • Maung Shwe;
    • Yan Xiang Gan;
    • Yin Ting Cheung;
    • Koon Mian Foo;
    • Mooi Tai Cham;
    • Jung Ah Lee;
    • Yee Pin Tan;
    • Fan, Gilbert;
    • Wei Sean Yong;
    • Madhukumar Preetha;
    • Wei-Jen Kiley Loh;
    • Si-Lin Koo;
    • Amit Jain;
    • Guek Eng Lee;
    • Wong, Mabel;
    • Dent, Rebecca;
    • Yoon Sim Yap
    Publication type:
    Article
    50